Immuno-oncology Drugs market

Immuno-oncology Drugs Market, Global Outlook and Forecast 2022-2028

  • 07 March 2022
  • Life Sciences
  • 125 Pages
  • Report code : PMR-6922146

  • 4.7 (158)

Immuno-oncology Drugs Market

COMPANIES COVERED

Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Dendreon Corporation
Agilent Technologies Inc.
Agenus Inc.
Enzo Biochem, Inc.
Lonza Group
Bio-Rad Laboratories, Inc.
Avantor, Inc.
Spring Bank Pharmaceuticals, Inc.
Ferring Pharmaceuticals

Download FREE Report Sample

  Download Free sample

Immunotherapy is treatment that uses a certain part of a person?s immune system to fight diseases which is done by stimulating one?s own immune system to work harder to attack cancer cells or by giving immune system components, such as man-made immune system proteins. Immunotherapy includes treatments that work in different ways. Some boost the body?s immune system in a very general way and others help train the immune system to attack cancer cells specifically.

Immuno-oncology Drugs Market contains market size and forecasts of Immuno-oncology Drugs in global, including the following market information:

Global Immuno-oncology Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Immuno-oncology Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Immuno-oncology Drugs companies in 2021 (%)

The global Immuno-oncology Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immune Checkpoint Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immuno-oncology Drugs include Amgen, Inc, AstraZeneca, Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., Hoffmann-La Roche AG, Johnson & Johnson and Novartis International AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Immuno-oncology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immuno-oncology Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Immuno-oncology Drugs Market Segment Percentages, by Type, 2021 (%)

Immune Checkpoint Inhibitors

Immune System Modulators

Cancer Vaccines

Oncolytic Virus

Others

Global Immuno-oncology Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Immuno-oncology Drugs Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Ambulatory Surgical Centers

Global Immuno-oncology Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Immuno-oncology Drugs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immuno-oncology Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Immuno-oncology Drugs revenues share in global market, 2021 (%)

Key companies Immuno-oncology Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Immuno-oncology Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Amgen, Inc

AstraZeneca, Plc

Bristol-Myers Squibb

Celgene Corporation

Eli Lilly and Company

Merck & Co.

Hoffmann-La Roche AG

Johnson & Johnson

Novartis International AG

AbbVie, Inc.

Pfizer Inc.

Sanofi S.A.

EMD Serono, Inc.

Gilead Sciences Inc.

Prometheus Therapeutics & Diagnostics

Aduro BioTech

Galena Biopharma

Bavarian Nordic

Celldex Therapeutics

ImmunoCellular Therapeutics

Incyte

Dendreon Corporation

Agilent Technologies Inc.

Agenus Inc.

Enzo Biochem, Inc.

Lonza Group

Bio-Rad Laboratories, Inc.

Avantor, Inc.

Spring Bank Pharmaceuticals, Inc.

Ferring Pharmaceuticals

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Immuno-oncology Drugs Market

Leave This Empty: